Health Services Research
Latest posts by Health Services Research (see all)
- Evaluating Area-Based Socioeconomic Status Indicators for Monitoring Disparities within Health… - Sep. 15, 2014
- Facing the Recession: How Did Safety-Net Hospitals Fare Financially Compared with Their Peers? - Sep. 15, 2014
- Hospital-Specific Template Matching for Auditing Hospital Cost and Quality - Sep. 08, 2014
- Young Adult Dependent Coverage: Were the State Reforms Effective? - Aug. 20, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.